|
Education
Education: BS in Pharmacy, MS in Pharmacy Practice
and PhD in Pharmaceutics, University of Washington
Research Interests
- treatment issues in patients with neurotrauma or epilepsy
- drug interactions and pharmacokinetics in women and children
- Drug interactions with alternative treatments
Courses Taught
- Pceut 405: Clinical Pharmacokinetics
- Pharm 562: Therapeutic III
- Pharm 410: Pharmacy and Women’s Health
Experience
Dr. Anderson completed a fellowship in Clinical
Pharmacokinetics at the State University of New York at Buffalo,
New York and an NIH training fellowship at the Regional Epilepsy
center at Harborview Medical Center in Seattle. She has been an
investigator on numerous federal and industry funded research grants
and is author of over fifty peer-reviewed publications. Dr. Anderson
is active in various Pharmacy and Epilepsy professional organizations
including the American Epilepsy Society and the Epilepsy Foundation
of Washington.
Selected Publications
Anderson GD.
A mechanistic approach to antiepileptic drug interactions. Annal
Pharmacotherapy 1998;32:554-563
Temkin NR, Jarell AB, Anderson GD.
Antiepileptogenic agents: How close are we? Drugs 2001;61:1045-1055.
Anderson GD. Sex
differences in drug metabolism: Cytochrome P450 and UDP glucuronoysltranasferase,
J Gender Specific Medicine 2001;5:25-33
Anderson GD.
Children vs. Adults: Pharmacokinetic and adverse effect differences.
Epilepsia. 2002;43 Suppl 3:53-59.
McAuley JW, Anderson GD. Treatment
of epilepsy in women of reproductive age: pharmacokinetic considerations.
Clin Pharmacokinet 2002;41(8):559-79.
Ethell BT, Anderson GD, Burchell
B. The effect of valproic acid on drug and steroid glucuronidation
by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol
2003;65:1141-1449.
Stehman-Breen C, Anderson
GD Gipson D, Ott-Ralph S. Pharmacokinetics of
Oral Micronized b-Estradiol in Postmenopausal Women with End-Stage
Renal Disease. Kidney Internal 2003;64:290-294.
Anderson GD,
Rosito G, Mohustsy MA, Elmer GW. Interaction potential of soy extract
and panax ginseng. J Clin Pharmacol 2003;43:643-648.
Anderson GD, Temkin NR, Chandler
WL, Winn HR. Effect of valproate on hemostatic function in patients
with traumatic brain injury. Epilepsy Research 2003:57:111-119.
Anderson GD, Odegard PS. Pharmacokinetics
of estrogen and progesterone in chronic kidney disease. Adv
Renal Replac Ther 2004; 11; 4:357-360.
Anderson GD.Pharmacogenetics
and Enzyme Induction/Inhibition Properties of the Antiepileptic
Drugs. Neurology 2004;63(Suppl 4):S3-S8.
Anderson GD.
Sex and Racial Differences in Pharmacological Response: Where is
the Evidence? Pharmacogenetics, pharmacokinetics and pharmacodynamics.
J Women's Health 2005;14:19-29.
Anderson GD,
Elmer GW, Kantor ED, Templeton IE, Vitiello MW. Pharmacokinetics
of valerenic acid after administration of valerian in healthy subjects.
Phytotherapy Research 2005;19:801-803.
Szot P, White SS, Shen DD, Anderson
GD. Valproic acid, but not lamotrigine, suppresses seizure-induced
c-fos and c-jun mRNA expression. Mol Brain Research 2005;135:285-289.
Anderson GD:
Pregnancy induced changes in pharmacokinetics: a mechanistic based
approach. Clin Pharmacokinetics 2005:10:1-19.
Mohustsky MA, Anderson GD, Miller
JW, Elmer GW. Ginkgo bilboa: evaluation of CYP2C9 drug interactions
in vitro and in vivo. Am J Ther 2006;13:24-31.
Li M, Anderson GD, Phillips
B, Kong W, Shen DD, Wang J: Interactions of amoxicillin and
cefaclor with human renal organic anion and peptide transporters.
Drug Metab Disposit, in press.
|
